Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Delila Gasi Tandefelt

Researcher

Delila Gasi Tandefelt
Researcher
Molecular characterization in prostate cancer for individualized medicine. Working with clinical sam
delila.gasi.tandefelt@gu.se
+46 31 786 6647
0766-186647

Room number: 4522B
Postal Address: Box 425, 41390 Göteborg
Visiting Address: Medicinaregatan 1F , 41390 Göteborg
Duties: Sahlgrenska Academy Research Fellow


Department of Urology at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
0313424145
Visiting Address: Bruna stråket 11b V 2 SU/Sahlgrenska , 413 45 Göteborg

Major publications

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
V Conteduca, D Wetterskog, M T A Sharabiani, E Grande, M P Fernandez-Perez et al.
Annals of oncology : official journal of the European Society for Medical Oncology, 2017

Plasma AR and abiraterone-resistant prostate cancer.
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Anuradha Jayaram, Nicola Casiraghi et al.
Science translational medicine, 2015

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration.
Jean Sebastien Frenel, Suzanne Carreira, Jane Goodall, Desam Roda, Raquel Perez-Lopez et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 2015

ETS fusion genes in prostate cancer.
Delila Gasi Tandefelt, Joost Boormans, Karin Hermans, Jan Trapman
Endocrine-related cancer, 2014

Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation.
Delila Gasi, Hetty A van der Korput, Hannie C Douben, Annelies de Klein, Corrina M de Ridder et al.
PloS one, 2011

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer.
Karin G Hermans, Joost L Boormans, Delila Gasi, Geert J H L van Leenders, Guido Jenster et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 2009

Latest publications

Identification of single nucleotide variants using position-specific error estimation in deep sequencing data.
Dimitrios Kleftogiannis, Marco Punta, Anuradha Jayaram, Shahneen Sandhu, Stephen Q Wong et al.
BMC medical genomics, Journal article 2019
Journal article

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
V Conteduca, D Wetterskog, M T A Sharabiani, E Grande, M P Fernandez-Perez et al.
Annals of oncology : official journal of the European Society for Medical Oncology, Journal article 2017
Journal article

Plasma AR and abiraterone-resistant prostate cancer.
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Anuradha Jayaram, Nicola Casiraghi et al.
Science translational medicine, Journal article 2015
Journal article

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration.
Jean Sebastien Frenel, Suzanne Carreira, Jane Goodall, Desam Roda, Raquel Perez-Lopez et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, Journal article 2015
Journal article

ETS fusion genes in prostate cancer.
Delila Gasi Tandefelt, Joost Boormans, Karin Hermans, Jan Trapman
Endocrine-related cancer, Review article 2014
Review article

A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers.
Delila Gasi Tandefelt, Joost L Boormans, Hetty A van der Korput, Guido W Jenster, Jan Trapman
European urology, Journal article 2013
Journal article

Androgen regulation of ETS gene fusion transcripts in prostate cancer.
Delila Gasi, Jan Trapman
Methods in molecular biology (Clifton, N.J.), Chapter in book 2011
Chapter in book

Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation.
Delila Gasi, Hetty A van der Korput, Hannie C Douben, Annelies de Klein, Corrina M de Ridder et al.
PloS one, Journal article 2011
Journal article

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer.
Karin G Hermans, Joost L Boormans, Delila Gasi, Geert J H L van Leenders, Guido Jenster et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, Journal article 2009
Journal article

Major publications

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
V Conteduca, D Wetterskog, M T A Sharabiani, E Grande, M P Fernandez-Perez et al.
Annals of oncology : official journal of the European Society for Medical Oncology, 2017

Plasma AR and abiraterone-resistant prostate cancer.
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Anuradha Jayaram, Nicola Casiraghi et al.
Science translational medicine, 2015

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration.
Jean Sebastien Frenel, Suzanne Carreira, Jane Goodall, Desam Roda, Raquel Perez-Lopez et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 2015

ETS fusion genes in prostate cancer.
Delila Gasi Tandefelt, Joost Boormans, Karin Hermans, Jan Trapman
Endocrine-related cancer, 2014

Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation.
Delila Gasi, Hetty A van der Korput, Hannie C Douben, Annelies de Klein, Corrina M de Ridder et al.
PloS one, 2011

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer.
Karin G Hermans, Joost L Boormans, Delila Gasi, Geert J H L van Leenders, Guido Jenster et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 2009

Showing 1 - 9 of 9

2019

Identification of single nucleotide variants using position-specific error estimation in deep sequencing data.
Dimitrios Kleftogiannis, Marco Punta, Anuradha Jayaram, Shahneen Sandhu, Stephen Q Wong et al.
BMC medical genomics, Journal article 2019
Journal article

2017

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
V Conteduca, D Wetterskog, M T A Sharabiani, E Grande, M P Fernandez-Perez et al.
Annals of oncology : official journal of the European Society for Medical Oncology, Journal article 2017
Journal article

2015

Plasma AR and abiraterone-resistant prostate cancer.
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Anuradha Jayaram, Nicola Casiraghi et al.
Science translational medicine, Journal article 2015
Journal article

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration.
Jean Sebastien Frenel, Suzanne Carreira, Jane Goodall, Desam Roda, Raquel Perez-Lopez et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, Journal article 2015
Journal article

2014

ETS fusion genes in prostate cancer.
Delila Gasi Tandefelt, Joost Boormans, Karin Hermans, Jan Trapman
Endocrine-related cancer, Review article 2014
Review article

2013

A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers.
Delila Gasi Tandefelt, Joost L Boormans, Hetty A van der Korput, Guido W Jenster, Jan Trapman
European urology, Journal article 2013
Journal article

2011

Androgen regulation of ETS gene fusion transcripts in prostate cancer.
Delila Gasi, Jan Trapman
Methods in molecular biology (Clifton, N.J.), Chapter in book 2011
Chapter in book

Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation.
Delila Gasi, Hetty A van der Korput, Hannie C Douben, Annelies de Klein, Corrina M de Ridder et al.
PloS one, Journal article 2011
Journal article

2009

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer.
Karin G Hermans, Joost L Boormans, Delila Gasi, Geert J H L van Leenders, Guido Jenster et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, Journal article 2009
Journal article

Showing 1 - 9 of 9

Page Manager: Katarina Olinder Eriksson|Last update: 1/7/2014
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?